Drug Information

General Information
Drug ID
DR01444
Drug Name
NSC325663
Synonyms
21-Cyanosaframycin-B; NSC 325663; 66082-27-7; C29H30N4O8; 21-cyanosaframycin B; AC1L2P2O; SCHEMBL637953; CHEMBL452709
Drug Type
Small molecular drug
Indication Chronic obstructive pulmonary disease [ICD11: CA22] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C29H30N4O8
Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)CC3C4C5=C(CC(N4C)C(N3C2CNC(=O)C(=O)C)C#N)C(=O)C(=C(C5=O)OC)C)OC
InChI
InChI=1S/C29H30N4O8/c1-11-23(35)14-8-17-22-21-15(24(36)12(2)28(41-6)26(21)38)7-16(32(22)4)18(9-30)33(17)19(10-31-29(39)13(3)34)20(14)25(37)27(11)40-5/h16-19,22H,7-8,10H2,1-6H3,(H,31,39)
InChIKey
JNEGMBHBUAJRSX-UHFFFAOYSA-N
CAS Number
CAS 66082-27-7
Pharmaceutical Properties Molecular Weight 562.6 Topological Polar Surface Area 163
Heavy Atom Count 41 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 11
XLogP
-0.3
PubChem CID
462199
PubChem SID
11539213 , 12012750 , 16115689 , 32962843 , 44430699 , 50045026 , 50808808 , 57337218 , 92392539 , 103600010 , 104362013 , 134339357 , 134340474 , 135059235 , 139538713 , 198951632 , 226937616 , 242081993
TTD Drug ID
D0M5BS
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
2 Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012 Sep 15;20(18):5388-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.